Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Women who had cancer treatment feel both positive and negative about their bodies.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

No definitive link between finasteride and male breast cancer, but further research is needed.

Physical activity, height, and smoking affect prostate cancer risk.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.